nightclaude · nightly deep dive · 2026-09-19
Cboe taxes market fear at $272.86, off $371.18 highs
Cboe Global Markets turns S&P panic into proprietary tolls, with $4.71B in 2025 revenue and $1.47B in operating income on exclusive SPX and VIX franchises. At $272.86 for a $28.50B market cap, 21.27 times trailing earnings, the question is whether a volatility compounder deserves a secular multiple.
In 1973 Cboe invented listed options in Chicago, and five decades later it still charges rent every time Wall Street panics. The 2025 machine did $4.71B in total revenue into $1.93B in gross profit and $1.10B in net income, at 54.1% gross margin and 34.6% operating margin, because SPX and VIX cannot trade anywhere else while cash equities can trade everywhere.
Yet at $272.86, down from a $371.18 52 week high for a $28.50B market cap and $27.72B enterprise value, trading at 21.27 times trailing earnings against a $315.64 target and a hold rating, the market calls it a cyclical toll booth priced as a compounder. This report asks if that verdict survives the numbers.
History & Ownership
Cboe Global Markets was born in Chicago in 1973 as the Chicago Board Options Exchange, the first U.S. venue dedicated to listed options, seeded by members of the Chicago Board of Trade. More than five decades later it is still headquartered in Chicago, Illinois, employs 1,661 people, and still thinks like a derivatives house first, with options and volatility as the crown jewels and equities, futures and FX as scale and distribution around them.
From member club to global exchange network
Cboe spent its first three decades as a member-owned mutual, the place where U.S. equity options were invented, standardized and scaled. It demutualized into CBOE Holdings and went public in 2010, joining CME Group, Nasdaq and Intercontinental Exchange as a listed, for profit exchange at the moment regulators and technology were forcing consolidation across trading venues.
The defining deal was Bats Global Markets, closed in 2017. Bats gave Cboe what it lacked: large U.S. equities market share, pan-European equities and clearing, and a modern technology stack. The company marked the break by changing its name from CBOE Holdings to Cboe Global Markets in October 2017. The SEC record captures the scale shift, with revenues rising from $175.08M in FY2016 to $2.23B in FY2017 on the enlarged base, followed by a long compounding run to $4.71B of total revenue in 2025, operating income of $1.47B in FY2025 versus $805.90M in FY2021, assets of $9.31B versus $6.81B in FY2021, and cash of $2.22B versus $341.90M in FY2021.
Today Cboe reports through five segments: Options, North American Equities, Europe and Asia Pacific, Futures, and Global FX. Unlike CME, which monetizes futures, or Nasdaq, which leans on listings and technology, Cboe monetizes exclusivity in index derivatives. Its strategic relationships with S&P Dow Jones Indices, Frank Russell Company and FTSE International underpin SPX options and VIX futures, products that cannot be traded anywhere else. That proprietary core explains why momentum has continued into 2026, with record quarterly net revenue of $731.6M, up 25% year over year, and an increased 2026 organic total net revenue growth target to mid to high teens, per ir.cboe.com, July 31, 2026.
Who owns it and how management acts
Cboe is a widely held, institutionally owned compounder with no controlling founder or parent:
- 1,424 institutions hold 91.26% of shares, with 91.49% of the float held by institutions, a classic large cap exchange register dominated by index and active managers.
- Insiders hold 0.25%, so management operates as hired stewards, not owner operators, with alignment through equity pay and capital return rather than control stock.
- Public float value is $28.50B at $272.86 per share, down from a $371.18 52 week high, leaving a liquid, non concentrated shareholder base.
Management character is disciplined toll collector, not empire builder. Capital intensity is minimal, with 2025 capital expenditure of only $71.00M against $1.75B of operating cash flow, and the surplus is pushed to owners: $284.30M of cash dividends paid and $66.70M of stock repurchased in 2025, while long term debt held flat at $1.44B and stockholders equity grew to $5.14B. Chief Financial Officer Jill Griebenow frames the story as transaction plus non transaction growth, with Derivatives setting quarterly records while Data Vantage and Cash and Spot Markets grow alongside, per ir.cboe.com, July 31, 2026. That is the Cboe playbook since Bats: protect the SPX and VIX moat, export the technology globally, and convert volume spikes into recurring data and recurring dividends.
Business Model & Strategy
Cboe Global Markets, founded in 1973 and headquartered in Chicago, operates as a derivatives and securities exchange network across North America, Europe and Asia Pacific with 1,661 employees. At $272.86 on September 18, 2026, the company is valued at a $28.50B market capitalization and $27.72B enterprise value. The 2025 engine produced $4.71B in total revenue, $1.93B in gross profit and $1.10B in net income, with $9.31B in assets, $5.14B in stockholders equity, $2.22B in cash and cash equivalents and $1.59B in total debt including $1.44B of long term debt. Profitability is exchange class, with 54.1% gross margin, 34.6% operating margin, 26.7% profit margin, 26.3% ROE and 11.6% ROA.
What Cboe Sells and To Whom
Cboe sells匹配, it sells execution, clearing, listings, market data and access. Customers are market makers, proprietary trading firms, brokers, retail brokerages, institutional asset managers, banks trading foreign exchange, and corporate and ETP issuers who list. The toll is taken three ways: transaction and clearing fees per contract or share, recurring access and capacity fees for low latency connectivity, and proprietary market data and licensing tied to its exclusive index franchises. Strategic relationships with S&P Dow Jones Indices, Frank Russell Company and FTSE International Limited underpin the proprietary products that carry the highest pricing power.
Operating Segments
| Segment | What It Monetizes |
|---|---|
| Options | SPX and other index options, single stock and ETP options across a single system, the core high margin franchise |
| North American Equities | U.S. equities and ETP transactions, BZX and Cboe Canada listings, market data |
| Europe and Asia Pacific | Pan European derivatives and equities, ETPs and depository receipts, listings and clearing |
| Futures | VIX futures and other futures, proprietary data licensing, access and capacity |
| Global FX | Institutional spot FX and non deliverable forwards on firm venues |
Recurring Versus Transactional Revenue
About two thirds of the economics are transactional and cyclical, driven by contracts traded times revenue per contract. That leverage was visible in the second quarter of 2026, when record net revenue of $731.6M, up 25% year over year, was led by record Options net revenue of $473.9M, up 30%, on 26% growth in total options average daily volume to 21.9 million contracts (per ir.cboe.com, July 2026 and per finance.yahoo.com, July 2026). Index options average daily volume hit a record 6.2 million contracts, up 32%, with total options revenue per contract up 6% to $0.317 (per finance.yahoo.com, July 2026). The balance is recurring and defensive: access and capacity fees, proprietary data feeds, index licensing passed through to users, and listing fees. Operating cash flow of $1.75B and free cash flow of $1.68B in 2025, against only $71.00M of capital expenditure, plus $284.30M in cash dividends paid, show how the recurring layer converts volatile volumes into cash.
Strategy and Competitive Flywheel
Cboe competes as the options specialist against CME Group and Intercontinental Exchange, described as the third player behind those giants with a pure play on volatility (per markets.financialcontent.com, February 2026). Its moat is exclusivity plus liquidity. Cboe is cited as the largest U.S. options exchange operator with consolidated share near 33% across four venues, anchored by exclusive SPX and VIX rights, with 13% to 15% share in U.S. equities (per matrixbcg.com, March 2026). The flywheel runs from exclusive benchmarks, to deepest liquidity, to tighter spreads that attract retail and institutional flow, to more transaction fees and more valuable data and access. Zero day to expiry SPX options, cited at 65% of SPX volume as of May 2026 (per investing.com, July 2026), accelerated that loop by turning daily hedging and retail speculation into structural volume. Management reinvests the rent into global trading hours, mini products, education through the Options Institute, and pan European clearing and listings, extending the same proprietary derivatives and data playbook from Chicago to Europe and Asia.
Segments & Products
Cboe Global Markets, Inc. is a derivatives and securities exchange network built around proprietary index franchises, with trading, clearing and investment solutions across the United States and internationally. The company, founded in 1973 and headquartered in Chicago with 1661 employees, reports through five segments: Options, North American Equities, Europe and Asia Pacific, Futures and Global FX. That structure produced $4.71B of total revenue in 2025 and $1.10B of net income in 2025, on $9.31B of assets against $4.17B of liabilities and $5.14B of stockholders equity, with $2.22B of cash and cash equivalents.
What each segment sells
| Segment | Core products | End market and monetization |
|---|---|---|
| Options | Index options, single stock options, ETP options on ETFs and ETNs through a single listed system | U.S. retail, institutional hedgers and market makers, paid by transaction and clearing fees plus market data and access |
| North American Equities | U.S. equities and ETP transaction services, ETP listings on BZX, listings on Cboe Canada | U.S. brokers and issuers, paid by transactions, listings and market data |
| Europe and Asia Pacific | Pan European derivatives, ETFs, ETNs, ETCs, depository receipts, listings and clearing | European and Asian institutions and issuers, paid by transactions, listings and clearing |
| Futures | VIX futures and other futures, proprietary data licensing, access and capacity | Volatility traders and hedgers, paid by transactions, data and connectivity |
| Global FX | Institutional spot FX and non deliverable forwards | Banks and buyside FX desks, paid by transaction services |
End markets: volatility hedging at the core, volume everywhere else
The economic center is U.S. options, and specifically exclusive index options tied to strategic relationships with S&P Dow Jones Indices, LLC, Frank Russell Company and FTSE International Limited. In the second quarter of 2026, Options net revenue was a record $473.9M, up 30% year over year, out of record quarterly net revenue of $731.6M, up 25% (per ir.cboe.com, July 2026). Total options average daily volume rose 26%, with index options average daily volume up 32% (per ir.cboe.com, July 2026). That leaves North American equities, European equities and derivatives, futures and FX as diversification and distribution: cash equities for bulk volume, Global FX for institutional flow, Futures as a pure volatility extension of the VIX franchise.
Pricing power: monopoly tolls versus commodity matches
Cboe has two different pricing regimes. In proprietary index options and VIX futures, where it owns the license and the listing, it charges a toll and expands revenue per contract. In the second quarter of 2026, total options revenue per contract rose 6% to $0.317, with index options revenue per contract up 3% as index mix increased (per finance.yahoo.com, July 2026). Market data fees were 20% higher and access and capacity fees were 19% higher in Options (per ir.cboe.com, July 2026). In multi listed equity options and cash equities, where it competes order by order with Nasdaq, NYSE, CME and wholesale internalizers, share is earned on technology and rebates. Cboe held 30% options market share, down from 30.2% a year earlier (per finance.yahoo.com, July 2026). The blended result still looks like an exchange moat: 54.1% gross margin, 34.6% operating margin, 26.7% profit margin, 26.3% ROE and 11.6% ROA, with $1.47B of operating income in 2025.
Growth drivers
- Structural options adoption: U.S. options volume is on pace for a seventh straight record year, with a single day high above 33.4M contracts on June 5 across Cboe exchanges during sharp market declines (per reuters.com, July 2026).
- 0DTE and SPX compounding: SPX options averaged 5.1M contracts per day, up 40% year over year, with 0DTE averaging 3.1M contracts per day, up 48%, and 0DTE representing 65% of SPX volume as of May 2026 (per finance.yahoo.com, July 2026 and per investing.com, July 2026).
- Global Trading Hours and retail: Record Global Trading Hours volume with strength from Asia Pacific, plus record Mini SPX activity, extends the SPX day and widens retail access (per s202.q4cdn.com, July 2026).
- Recurring data and access: Market data, access and capacity growth attached to higher volumes turns cyclical trading spikes into stickier subscription like revenue.
The question for investors is mix. When volatility rises, the high margin proprietary complex drives $473.9M quarters and funds the rest of the network. When it fades, Cboe leans on listings, FX, European derivatives and recurring connectivity to hold the $4.71B base until the next hedging wave.
Operations & Go-to-Market
Cboe Global Markets is a pure infrastructure business. With 1,661 employees headquartered in Chicago, where it was founded in 1973, it operates an electronic derivatives and securities exchange network that turns volatility and volume into transaction and clearing fees, market data licenses, and access and capacity charges. Scale is visible in the 2025 income statement, with total revenue of $4.71B, gross profit of $1.93B and operating income of $1.47B, a profile that reflects software-like incremental margins on matched flow rather than balance sheet risk.
Delivery footprint: exchanges, clearing, data pipes
Cboe does not manufacture. It matches. Delivery is five transaction engines plus clearing and data distribution, run on a single system for listed options in the U.S. and pan-European and Asia Pacific venues for equities, derivatives and ETPs. Clearing is vertically owned in Europe through Cboe Clear Europe, which is now expanding securities financing clearing into fixed income, while U.S. options and futures clear through OCC and CFTC regulated channels. The Futures segment monetizes VIX futures and other futures products alongside licensing of proprietary market data and access and capacity services, a classic exchange bundle of execution, pipe and content.
| Segment | What it delivers operationally |
|---|---|
| Options | Index, single stock and ETP options, including SPX, through one listed system |
| North American Equities | U.S. equities and ETP transactions, ETP listings on BZX, listings on Cboe Canada, market data |
| Europe and Asia Pacific | Pan-European derivatives and equities, ETPs and depository receipts, listings, clearing |
| Futures | VIX futures, proprietary data licensing, access and capacity |
| Global FX | Institutional FX and non-deliverable forward execution |
Distribution and sales model: B2B toll booth, B2B2C reach
Cboe sells to intermediaries, not end investors. Market makers, proprietary trading firms, bank and nonbank liquidity providers, institutional FX participants, retail brokers and ETP issuers pay per contract, per share or per subscription. Retail arrives wholesale, routed by brokers into Cboe's proprietary index options and multi-listed options, which explains why product design now targets the retail day trader directly. Zero day to expiration SPX options represented 65% of SPX volume as of May 2026 (per investing.com, July 2026), and Mini-SPX quarterly average daily volume hit 195,000 contracts, up 80% year over year (per s202.q4cdn.com, July 2026). Listings is the other acquisition funnel. Cboe captured 44% of all new ETF launches in 2026 to rank first ahead of NYSE and Nasdaq (per cryptobriefing.com, May 2026), feeding future transaction and data revenue even though NYSE retains 52% of total listings and 66% of ETF trading volume.
Vertical integration: own the exclusive, rent the commodity
The moat is contractual exclusivity stacked on owned infrastructure. Cboe licenses flagship indices through strategic relationships with S&P Dow Jones Indices, Frank Russell Company and FTSE International Limited, then owns the only venue for SPX options and the VIX futures complex. That proprietary flow carried record Options net revenue of $473.9 million in the second quarter of 2026, up 30% year over year on 26% growth in total options average daily volume to 21.9 million contracts and a 6% increase in revenue per contract to $0.317 (per ir.cboe.com, July 2026, and finance.yahoo.com, July 2026). Multi-listed options, U.S. equities and European cash are commodity flow where Cboe competes on technology, pricing tiers and data. Management's answer since the second half of 2025 has been to prune the commodity tail, with an agreed sale of Cboe Canada and Cboe Australia, wind downs of corporate listings, European derivatives on CEDX and Japanese equities, and cost cuts in ETP listings and analytics (per s202.q4cdn.com, 2026).
Geographic exposure: American derivatives, global distribution
Economically, Cboe is American derivatives with international distribution. North America drives the profit pool through index options, VIX futures and U.S. equities transactions, while Europe and Asia Pacific provides diversification in pan-European trading, clearing and listings plus a growth vector for proprietary data. Total net revenue hit a record $731.6 million in the second quarter of 2026, up 25% year over year with growth in all segments and index options average daily volume at a record 6.2 million contracts (per reuters.com, July 2026). The 2026 go-to-market push extends that core outward: daily expirations for Dow Jones Industrial Average index options, extended hours for multi-listed single stock options, a patent pending prediction markets framework starting with Mini-SPX, and a filing for near 24x5 U.S. equities trading (per ir.cboe.com, September 2026).
Financials
At $272.86, Cboe carries a $28.50B market cap and $27.72B enterprise value, trading at 21.27x trailing earnings, 17.92x forward earnings and 14.36x EV/EBITDA (per yfinance). The Street sees $315.64 on average with a hold recommendation (per yfinance), a modest premium to a business that already prices like a compounder.
| Metric (source) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Total Revenue (per yfinance) | $3.96B | $3.77B | $4.09B | $4.71B |
| Gross Profit (per yfinance) | $1.38B | $1.49B | $1.61B | $1.93B |
| Operating Income (per EDGAR) | $489.60M | $1.06B | $1.10B | $1.47B |
| Net Income (per EDGAR) | $235.00M | $761.40M | $764.90M | $1.10B |
| Diluted EPS (per yfinance) | $2.19 | $7.13 | $7.21 | $10.42 |
| EBITDA (per yfinance) | $659.70M | $1.27B | $1.27B | $1.74B |
| Free Cash Flow (per yfinance) | $591.30M | $1.03B | $1.04B | $1.68B |
| Cash (per EDGAR) | $432.70M | $543.20M | $920.30M | $2.22B |
| Total Debt (per yfinance) | $1.87B | $1.61B | $1.60B | $1.59B |
| Equity (per EDGAR) | $3.47B | $3.98B | $4.28B | $5.14B |
Revenue: the trajectory is a step change followed by steady compounding. Total revenue was $4.71B in FY2025, up from $4.09B in FY2024 and $3.77B in FY2023 after $3.96B in FY2022 (per yfinance), with year over year growth last reported at 22.9% (per yfinance). The longer EDGAR series shows why scale inflected, with revenues of $141.83M in FY2013, $155.95M in FY2015 and $175.08M in FY2016 exploding to $2.23B in FY2017 (per EDGAR), the Bats acquisition that built the current multi venue network.
Margins and returns: this is a toll booth. Gross margin is 54.1%, operating margin is 34.6% and profit margin is 26.7% (per yfinance). Gross profit reached $1.93B in FY2025 versus $1.61B in FY2024 and $1.49B in FY2023 (per yfinance). Operating income was $1.47B in FY2025 versus $1.10B in FY2024, $1.06B in FY2023 and $489.60M in FY2022, after $805.90M in FY2021 (per EDGAR). Net income was $1.10B in FY2025 versus $764.90M in FY2024 and $761.40M in FY2023, up from $235.00M in FY2022 (per EDGAR). Diluted EPS was $10.42 in FY2025 versus $7.21 in FY2024, $7.13 in FY2023 and $2.19 in FY2022 (per yfinance). EBITDA was $1.74B in FY2025 versus $1.27B in both FY2024 and FY2023 and $659.70M in FY2022 (per yfinance). Returns confirm capital lightness, with ROE of 26.3% and ROA of 11.6% (per yfinance).
Balance sheet: cash now exceeds debt. Cash was $2.22B in FY2025 versus $920.30M in FY2024, $543.20M in FY2023 and $432.70M in FY2022 (per EDGAR). Total debt was $1.59B in FY2025 versus $1.60B in FY2024 and $1.61B in FY2023, with long term debt flat at $1.44B in each year from FY2022 to FY2025 (per yfinance). Total assets were $9.31B in FY2025 versus $7.79B in FY2024 and $7.49B in FY2023 (per EDGAR). Total liabilities were $4.17B in FY2025 versus $3.51B in FY2024 and $3.50B in FY2023 (per EDGAR). Stockholders equity was $5.14B in FY2025 versus $4.28B in FY2024, $3.98B in FY2023 and $3.47B in FY2022 (per EDGAR). That explains an enterprise value of $27.72B below the $28.50B market cap (per yfinance).
Cash flow and capital allocation
Conversion is elite because capex is trivial. Operating cash flow was $1.75B in FY2025 versus $1.10B in FY2024, $1.08B in FY2023 and $651.10M in FY2022 (per yfinance). Free cash flow was $1.68B in FY2025 versus $1.04B in FY2024, $1.03B in FY2023 and $591.30M in FY2022 (per yfinance), on capital expenditure of only $71.00M in FY2025, $60.90M in FY2024 and $45.00M in FY2023 (per yfinance). Management pays a growing dividend and buys opportunistically, with cash dividends paid of $284.30M in FY2025 versus $249.40M in FY2024 and $223.50M in FY2023, and repurchases of $66.70M in FY2025 after $204.80M in FY2024, $83.90M in FY2023 and $100.90M in FY2022 (per yfinance).
Momentum carried into 2026. Cboe posted record quarterly net revenue of $731.6M, up 25% year over year, with diluted EPS of $3.35, up 50%, and adjusted diluted EPS of $3.56, up 45% (per ir.cboe.com, July 2026). It raised the 2026 organic total net revenue growth target to mid to high teens and the Data Vantage target to low teens while reaffirming adjusted operating expense guidance of $838M to $853M (per ir.cboe.com, July 2026), with Options net revenue up 30% to $473.9M on 26% higher options average daily volume (per stocktitan.net, July 2026).
Revenue & net income by fiscal year ($B)
Margin trend by fiscal year
Competitive Landscape & Moat
Cboe Global Markets, at $272.86 and a $28.50B market cap with a $27.72B enterprise value, is the purest listed play on U.S. equity derivatives volume. The 2025 base is $4.71B in total revenue, $1.47B in operating income and $1.10B in net income on $9.31B in assets, with $2.22B in cash against $1.59B in total debt. That converts to a 54.1% gross margin, 34.6% operating margin, 26.7% profit margin, 26.3% ROE and 11.6% ROA, priced at 21.27 times trailing earnings, 17.92 times forward earnings and 14.36 times EV to EBITDA. The business runs through five segments: Options, North American Equities, Europe and Asia Pacific, Futures and Global FX, with 1,661 employees operating exchanges in the U.S., Canada, Europe, Asia Pacific and a global FX venue.
An oligopoly where Cboe owns volatility
The direct set is CME Group, Intercontinental Exchange and Nasdaq, plus a second tier of multi-listed options venues including MIAX, NYSE Arca and BOX. It is routinely described as the third player behind CME and ICE that owns the equity index options niche while CME owns rates and commodities futures (per markets.financialcontent.com, February 2026). The split is functional. Cboe rarely fights CME contract for contract. It fights for institutional risk capital and retail order flow that expresses itself in S&P 500 Index options (SPX), Cboe Volatility Index (VIX) options and futures, and zero day to expiry (0DTE) trading.
In Q2 2026 Cboe reported record quarterly net revenue of $731.6 million, up 25% year over year, with Options net revenue of $473.9 million up 30% (per ir.cboe.com, July 2026). Total options average daily volume rose 26% to 21.9 million contracts, with index options average daily volume of 6.2 million contracts up 32% (per investing.com, July 2026). SPX average daily volume hit 5.1 million contracts, up 40%, with 0DTE average daily volume of 3.1 million contracts up 48%, and 0DTE represented 65% of SPX volume as of May 2026 (per investing.com, July 2026). SPX accounted for 81% of all index options trading in the quarter (per cboe.com, Q2 2026 roundup). On June 5 the complex printed a single day record of 33.4 million contracts as volatility spiked (per reuters.com, July 2026). That is the lead: exclusive, cash settled SPX and VIX franchises that cannot legally trade elsewhere, amplified by weekly and daily expiries and a retail mini SPX contract that did 195,000 contracts a day in the quarter, up 80% (per investing.com, July 2026).
Where it lags
- Multi-listed options share: Cboe options exchanges held 29.1% total options market share in Q1 2026, down from 31.1% a year earlier, with multi-listed share at 22.3% (per ir.cboe.com, May 2026). Single stock and ETF options list everywhere, so Nasdaq, NYSE, MIAX and BOX compete purely on pricing, technology and payment for order flow. Cboe wins on capture, not always on share.
- Futures breadth vs. CME: Cboe Futures is essentially VIX futures plus smaller equity index products, while CME monetizes rates, equity index, energy, metals, agriculture and crypto across a far larger futures and clearing complex. Cboe discloses licensing of proprietary market data plus access and capacity fees in Futures, but it has no answer to CME scale in a rates led volume regime.
- Equities, listings and data vs. Nasdaq and ICE: Nasdaq has pivoted toward software, data and index licensing while ICE compounds mortgage technology, data and NYSE listings. Cboe North American Equities (BZX listings, U.S. equities transactions, Cboe Canada) and Europe and Asia Pacific (pan European trading, clearing, listings) are share takers in a low capture, high scale business. They lack the corporate listings monopoly rents of NYSE and Nasdaq and the recurring software mix Nasdaq now sells.
- Global FX: institutional spot and non deliverable forwards face EBS, LSEG Matching, Currenex and bank internalizers. It is a useful diversifier, not a moat product.
The moat: exclusivity plus liquidity plus license
1. Exclusive index rights. Strategic relationships with S&P Dow Jones Indices, Frank Russell Company and FTSE International Limited underpin SPX, Russell and related products. That is a contractual moat, not just a network effect. A competitor can list Apple options tomorrow. It cannot list SPX.
2. Liquidity flywheel and switching costs. Market makers quote SPX and VIX because the tightest spread and deepest book are on Cboe. Hedgers route there because market makers are there. The 6% rise in total options revenue per contract alongside 26% volume growth in Q2 2026 (per ir.cboe.com, July 2026), to about $0.317 per contract, shows pricing power inside the exclusive complex even as multi-listed capture is competed away. The installed base is brokers, designated market makers, volatility desks and now retail 0DTE flow stitched in through Schwab, Fidelity, Robinhood and Interactive Brokers distribution.
3. Regulation as barrier. National securities exchange registration, self regulatory obligations, clearing linkages and pan European regulated market status make a de novo index options exchange prohibitively slow and expensive. That protects the $1.75B in 2025 operating cash flow and $1.68B in free cash flow, with only $71.00M in capital expenditure and $284.30M in cash dividends paid, and explains why the balance sheet carries $5.14B in stockholders equity on a lightly levered exchange model.
The risk is concentration. When SPX and VIX go quiet, Cboe has less cushion than CME or ICE. When they spike, as in Q2 2026 with 45% adjusted diluted earnings growth (per ir.cboe.com, July 2026), no competitor collects that toll. Trading at $272.86, still well below the $371.18 52 week high and above the $227.15 low, against a $315.64 mean target and a hold consensus, the market is pricing Cboe as a high margin volume compounder with a one franchise moat, dominant in its pit and a price taker everywhere else.
Verdict & Valuation
Verdict: Buy the monopoly, fade the volume panic. At $272.86, Cboe Global Markets is priced as a cyclical toll booth trading at 21.27 times trailing earnings, 17.92 times forward earnings and 14.36 times EV/EBITDA. The business underneath is a proprietary index franchise with violent operating leverage, a net cash balance sheet and a secular options tailwind that commoditized exchange comps like Nasdaq, NYSE, MEMX, MIAX and BOX cannot replicate in SPX and VIX.
The bear case is not wrong about cyclicality, it is wrong about price. Cboe has already derated about 26% from the $371.18 52 week high while fundamentals accelerated, leaving the stock well above the $227.15 low with a 17.2% 1 year return and a 137.9% 5 year return. Consensus at $315.64 on a hold recommendation implies about 15.7% upside from $272.86, a modest ask for 26.3% return on equity, 11.6% return on assets, 54.1% gross margin, 34.6% operating margin and 26.7% profit margin.
Why the bull wins: exclusive flow at scale
Cboe is not splitting multilist pennies. Its five segments, Options, North American Equities, Europe and Asia Pacific, Futures and Global FX, are anchored by exclusive SPX, VIX and XSP volume under strategic relationships with S and P Dow Jones Indices, Frank Russell Company and FTSE International. That exclusivity is widening, not narrowing. Cboe reported a quarterly average daily volume record of 6.2 million contracts for proprietary index options and a single day record of 33.4 million contracts on June 5, per ir.cboe.com, July 2026. Index options averaged 6.1 million contracts daily in the first quarter with SPX at a record average daily volume of 4.9 million, per cboe.com, 2026. CME Group and Intercontinental Exchange own futures and clearing, Nasdaq owns listings and data, but no one else prints the SPX ticket.
Growth is reaccelerating with classic exchange leverage. Total revenue reached $4.71B in 2025 versus $4.09B in 2024 and $3.77B in 2023, with 22.9% year over year revenue growth flagged by yfinance. SEC XBRL facts put 2025 operating income at $1.47B versus $1.10B in 2024 and $1.06B in 2023, and net income at $1.10B, with diluted earnings per share at $10.42 versus $7.21 in 2024. Gross profit was $1.93B. Momentum carried into the second quarter with record net revenue of $731.6 million, up 25%, diluted earnings per share of $3.35, up 50%, and adjusted diluted earnings per share of $3.56, up 45%, per ir.cboe.com, July 2026. Options drove it, with total options average daily volume up 26% and Options revenue up about 30%, per zacks.com, September 2026. Management then raised 2026 organic total net revenue growth guidance to mid to high teens, per zacks.com, September 2026.
Cash compounder, fortress balance sheet
This is a cash machine that does not need capital. Operating cash flow was $1.75B in 2025 and free cash flow was $1.68B on capital expenditure of only $71.00M, versus $1.10B and $1.04B in 2024. Cash and cash equivalents ended 2025 at $2.22B versus $920.30M in 2024, $543.20M in 2023 and $432.70M in 2022, against total debt of $1.59B and long term debt flat at $1.44B. That is why enterprise value of $27.72B sits below market cap of $28.50B. Total assets are $9.31B, liabilities are $4.17B and equity is $5.14B. Distributions are compounding, with cash dividends paid of $284.30M and repurchase of capital stock of $66.70M in 2025, up from $249.40M of dividends in 2024. EBITDA of $1.74B at 14.36 times enterprise value is cheap for this return profile.
The secular leg extends the day. Mini SPX set a monthly average daily volume record of 238 thousand contracts and Global Trading Hours set a monthly average daily volume record of 224 thousand contracts including record SPX Global Trading Hours volume of 197 thousand contracts, per ir.cboe.com, August 2026. With 1,661 employees, 1,424 institutions holding 91.26% of shares and insiders holding 0.25%, the register is tightly held by sophisticated owners. The 5 year range of $99.53 to $364.92 tells the story: every volatility drought has been bought because SPX, VIX, 0DTE and overnight volume keep compounding.
What the bears get right, and why it is insufficient
Cyclicality is real. SEC XBRL operating income fell from $805.90M in 2021 to $489.60M in 2022 before rebounding to $1.06B in 2023, $1.10B in 2024 and $1.47B in 2025. Transaction and clearing fees live and die with average daily volume. Concentration is real. Lose pricing or exclusivity on SPX and VIX and the $1.68B of free cash flow has a single point of failure. Share loss in commoditized options and North American equities, where maker taker rebates and payment for order flow rule, is real. A crowded register with 91.26% institutional ownership and 0.25% insider ownership offers no cushion if volume mean reverts.
But the multiple already pays for that fear. A 17.92 forward multiple for mid to high teens organic growth, 34.6% operating margin and 26.3% return on equity is not perfection pricing, it is a discount to secular data and exchange peers that lack an exclusive index. The raised guide is not a trap, it is math from record proprietary flow plus Data Vantage and Cash and Spot Markets breadth.
What would change the view
- Proprietary volume rolls over for two quarters. If SPX and index options average daily volume stall while multilist share keeps leaking to MIAX, BOX and MEMX, the $1.47B operating income base and $1.75B operating cash flow cannot hold the 21.27 multiple. Cut on loss of the 6.2 million proprietary record trend.
- Non transaction growth fails while expenses creep. If Data Vantage stops compounding and adjusted operating expenses break above discipline, the smoothing story dies and Cboe becomes a pure volatility future. Add on continued Global Trading Hours and XSP records with expenses contained.
| Metric | Value |
|---|---|
| Price | $272.86 |
| 52 week high / low | $371.18 / $227.15 |
| Market cap / Enterprise value | $28.50B / $27.72B |
| Trailing P/E / Forward P/E / EV/EBITDA | 21.27 / 17.92 / 14.36 |
| Analyst target mean | $315.64 |
| 2025 revenue / gross profit / EBITDA | $4.71B / $1.93B / $1.74B |
| 2025 operating income / net income / EPS | $1.47B / $1.10B / $10.42 |
| Cash / total debt / equity | $2.22B / $1.59B / $5.14B |
The Bull Case
- A proprietary index monopoly that competitors cannot replicate Cboe is not another commoditized cash equities venue splitting multi list volume with Nasdaq, NYSE and MEMX at pennies of capture. Its Options segment owns exclusive SPX, VIX and XSP volume under strategic relationships with S&P Dow Jones Indices, Frank Russell and FTSE International, products that traded a total of 1.2 billion contracts in 2025 with SPX alone at 970.6 million contracts and average daily volume of 3.9 million contracts (per ir.cboe.com, January 2026). The moat widened in 2026: proprietary index options set a quarterly average daily volume record of 6.1 million contracts and SPX set a quarterly record of 4.9 million, with SPX zero days to expiry at a record 3.0 million (per ir.cboe.com, April 2026). That pricing power showed in Q2 2026 when Options net revenue rose 30% to $473.9 million on 26% higher total options average daily volume (per finance.yahoo.com, July 2026).
- Growth reaccelerating with violent operating leverage Total revenue reached $4.71B in 2025 versus $4.09B in 2024 and $3.77B in 2023, with yfinance flagging 22.9% year over year revenue growth, gross profit of $1.93B for a 54.1% gross margin, operating margin of 34.6% and profit margin of 26.7%. SEC XBRL facts put 2025 operating income at $1.47B versus $1.10B in 2024 and $1.06B in 2023, and net income at $1.10B versus $764.90M in 2024 and $761.40M in 2023, with diluted EPS at $10.42 versus $7.21. Return on equity is 26.3% on equity of $5.14B and return on assets is 11.6% on assets of $9.31B. Momentum continued into Q2 2026 with record net revenue of $731.6 million, up 25%, adjusted diluted EPS of $3.56, up 45%, and diluted EPS of $3.35, up 50% (per ir.cboe.com, July 2026), beating consensus at $700.1 million and $3.36 (per investing.com, July 2026) while adjusted operating expenses rose just 2% (per investing.com, July 2026). Management raised the 2026 organic total net revenue growth target to mid to high teens from low double digit to mid teens while reaffirming adjusted operating expense guidance of $838 million to $853 million (per ir.cboe.com, July 2026).
- A cash compounder with a fortress balance sheet Operating cash flow was $1.75B in 2025 and free cash flow was $1.68B versus $1.10B and $1.04B in 2024, on capital expenditure of only $71.00M. Cash and cash equivalents ended 2025 at $2.22B versus $920.30M in 2024, $543.20M in 2023 and $432.70M in 2022, against total debt of $1.59B and long term debt flat at $1.44B. That is why enterprise value of $27.72B sits below market cap of $28.50B. The surplus funds compounding distributions: cash dividends paid of $284.30M and repurchase of capital stock of $66.70M in 2025, up from $249.40M and $204.80M in 2024. EBITDA of $1.74B supports an EV/EBITDA multiple of only 14.36.
- Secular options boom plus recurring data to smooth the cycle Cboe runs five segments across Options, North American Equities, Europe and Asia Pacific, Futures and Global FX, spanning equities, derivatives and FX across North America, Europe and Asia Pacific, so it monetizes volatility, volume and subscriptions. Industry volume hit market wide average daily volume of 68.6 million contracts in Q1 2026 with index options up 22% and SPX at a record 4.9 million (per cboe.com, 2026), then 72.8 million in Q2, up more than 19% year over year (per cboe.com, 2026). Cboe's 2025 total options volume of 4.6 billion contracts at average daily volume of 18.4 million was its sixth consecutive record year, with SPX zero days to expiry at a record 2.3 million contracts or 59% of SPX volume (per ir.cboe.com, January 2026). New legs are extending the day: Global Trading Hours set a monthly average daily volume record of 224 thousand contracts in July 2026 including record SPX Global Trading Hours volume of 197 thousand, while mini SPX set a record 238 thousand (per finance.yahoo.com, August 2026), and Cboe raised its Cboe Data Vantage organic net revenue growth target to low teens (per ir.cboe.com, July 2026).
- Discounted price for accelerating fundamentals At a last close of $272.86 on September 18, 2026, Cboe trades about 26% below its 52 week high of $371.18 and well above its 52 week low of $227.15, with a 5 year range of $99.53 to $364.92, a 1 year return of 17.2% and a 5 year return of 137.9%. The valuation is 21.27 times trailing earnings and 17.92 times forward earnings against an analyst target mean of $315.64 and a hold recommendation, a modest multiple for 26.3% return on equity, 34.6% operating margin and mid to high teens organic growth guidance. With 1,661 employees, 1,424 institutions holding 91.26% of shares and insiders holding 0.25%, the float is tightly held by sophisticated owners positioned for continued SPX, VIX, 0DTE and overnight volume compounding.
The Bear Case
- Perfection pricing on a transaction tax At $272.86, CBOE carries a $28.50B market cap and $27.72B enterprise value, trading at 21.27 times trailing earnings, 17.92 times forward earnings and 14.36 times EV/EBITDA. That is a secular compounder multiple for a volume toll, after a 137.9% five year run and about 26.5% below the $371.18 52 week high and well above the $227.15 low, with consensus at $315.64 on a hold recommendation. If record quarterly net revenue of $731.6M, up 25%, and adjusted diluted EPS of $3.56, up 45% (per ir.cboe.com, July 2026), marks the peak of the volatility harvest, there is no multiple cushion.
- Cyclical revenue dressed as secular growth Total revenue of $4.71B in 2025, up from $4.09B in 2024, with gross profit of $1.93B at a 54.1% gross margin, operating margin of 34.6% and profit margin of 26.7%, plus 22.9% year over year revenue growth, all scream late cycle. SEC XBRL operating income fell from $805.90M in FY2021 to $489.60M in FY2022 before rebounding to $1.06B in FY2023, $1.10B in FY2024 and $1.47B in FY2025, while net income traced the same whipsaw from $529.00M to $1.10B. When VIX futures, 0DTE and index options ADV normalize, transaction and clearing fees, the core of the Options and Futures segments, normalize with them.
- A two ticker concentration risk CBOE discloses strategic dependence on S and P Dow Jones Indices, Frank Russell Company and FTSE International, and the tape shows why. SPX accounted for 81% of all index options trading in the second quarter, SPY was 42% of ETF options volume, and Nvidia and Tesla each took 9% of single stock volume (per cboe.com, Q2 2026), while 98.2% of index option volume traded on CBOE venues and VIX options ADV hit one million contracts (per cboe.com, Q1 2026). Lose pricing, exclusivity or relevance on SPX and VIX, or suffer a sustained volatility drought and a rotation away from 0DTE lottery tickets, and the $1.74B of EBITDA and $1.68B of 2025 free cash flow have a single point of failure.
- Losing share in the market it created CBOE Options exchanges had total market share of 29.1% for the first quarter of 2026, down from 31.1% in the first quarter of 2025 (per ir.cboe.com, May 2026), and 30.0% for the second quarter of 2026, down from 30.2% a year earlier (per ir.cboe.com, July 2026), even as market wide ADV hit 68.6 million contracts in Q1 and 72.8 million in Q2. Nasdaq, NYSE, MIAX, BOX and Members Exchange live on maker taker rebates and payment for order flow in multi listed options and North American equities, while CME Group and Intercontinental Exchange dominate futures and clearing and Nasdaq dominates listings and data. CBOE wins only where it owns the index, everywhere else it discounts.
- The raised guide is the trap, the payout proves it Management lifted 2026 organic total net revenue growth to mid to high teens from low double digit to mid teens and Data Vantage to low teens (per ir.cboe.com, July 2026), while holding adjusted operating expense guidance at $838M to $853M, setting a comp that requires record volatility to repeat. Cash of $2.22B against total debt of $1.59B, including $1.44B long term, on $9.31B of assets, $4.17B of liabilities and $5.14B of equity looks fortress like until you see 2025 capital return: only $66.70M of stock repurchased versus $284.30M of cash dividends paid, with 91.26% institutional ownership and 0.25% insider ownership. A crowded, low insider conviction register, a 26.3% ROE flattered by a thin equity base, and operating cash flow of $1.75B that lives and dies with ADV is exactly what derates when volume mean reverts.
Key Risks
- 1. SPX and volatility franchise concentration. Cboe lives or dies on proprietary index options and VIX futures licensed from S&P Dow Jones Indices, Frank Russell and FTSE.
- 2. Volatility cyclicality. Transaction revenue surges when volatility spikes and stalls when markets go quiet.
- 3. U.S. options market structure reform. The SEC is actively reexamining payment for order flow, auctions, tick sizes and fragmentation.
- 4. Commoditized equities, European and FX share loss. Outside its moat, Cboe fights Nasdaq, Intercontinental Exchange, CME Group and bank internalizers on price.
- 5. Full multiple with concentrated positioning. At $272.86, down from a $371.18 52 week high, with 91.3% institutional ownership, expectations leave little room for a volume miss.
1. The SPX, 0DTE and S&P dependency is extreme
Cboe Global Markets, founded in 1973 and headquartered in Chicago with 1,661 employees, discloses five segments, Options, North American Equities, Europe and Asia Pacific, Futures and Global FX, but the economics are dominated by one: listed options on proprietary S&P indices, plus VIX futures. That showed again when second quarter 2026 Options net revenue hit a record $473.9M, up 30% year over year, on a 26% rise in total options average daily volume and a 32% rise in index options average daily volume to 6.2 million contracts, per reuters.com, July 2026 and per fool.com, August 2026. Total net revenue in that quarter was a record $731.6M, up 25%, per ir.cboe.com, July 2026, meaning options alone carried the quarter. Contrast that with North American cash equities, European derivatives and spot FX, where Cboe is one of many venues competing with Nasdaq, NYSE, MIAX, BOX, CME, LSEG and 360T, and where Cboe has no exclusive index.
The strategic relationships named in the company summary, S&P Dow Jones Indices, Frank Russell Company and FTSE International Limited, are strengths until they are renegotiated. Loss, non renewal or repricing of the S&P license, creation of competing S&P linked products elsewhere, or a shift in 0DTE behavior after a volatility shock or retail loss event would hit the highest margin flow first. Cboe reported 2025 total revenue of $4.71B, gross profit of $1.93B for a 54.1% gross margin, operating income of $1.47B on an SEC EDGAR basis and net income of $1.10B for a 26.7% profit margin. That operating leverage works in reverse if index revenue per contract slips.
What would confirm this risk: Index options average daily volume decelerates while cash equities and FX volumes hold up, and management discloses a lower revenue per contract or higher index license cost in Options.
2. A calm market breaks the model
Exchanges sell tolls on fear and activity. Cboe just posted 22.9% year over year revenue growth and second quarter 2026 adjusted diluted earnings of $3.56, up 45%, per fool.com, August 2026, because volatility returned. In a low volatility grind with tight spreads and falling turnover, options hedging, 0DTE speculation and VIX futures rolls all compress at once. That cyclicality is visible in history: SEC EDGAR operating income fell to $489.60M in 2022 from $805.90M in 2021 before rebounding to $1.06B in 2023 and $1.47B in 2025, while yfinance net income fell to $235.00M in 2022 before rebounding to $1.10B in 2025. CME Group and Intercontinental Exchange can lean on rates, energy and clearing balances in that tape. Cboe, as a derivatives led venue, cannot.
Management leaned into the cycle by raising the full year organic net revenue outlook to growth in the mid to high teens range from low double digit to mid teens, per reuters.com, July 2026. Recent commentary themes around a seventh straight record year for U.S. options volume frame that as durable, but that narrative is sentiment, not a contract. If VIX stays low for two quarters, the $1.75B of 2025 operating cash flow and $1.68B of 2025 free cash flow become the bear case exhibit for how fast $28.50B of market capitalization and $27.72B of enterprise value can derate.
What would confirm this risk: Reported total options average daily volume and Futures net transaction fees fall quarter over quarter while the VIX and realized correlation stay low, even as U.S. equity indices rise.
3. Washington can rewrite the options toll
The SEC convened an Options Market Structure Roundtable on April 16, 2026 to review execution quality, competition and fragmentation, per sec.gov, April 2026, with law firm summaries noting debate over specialist allocations, price improvement auctions and exchange entry incentives, per sidley.com, April 2026. That matters because Cboe operates four U.S. options exchanges and monetizes order flow segmentation, complex order auctions, proprietary data and access fees. Any ban or curb on payment for order flow, mandate for order competition or auction reform, compression of access fees, or expansion of tick constrained quoting to $0.005 increments would compress revenue per contract or force technology reinvestment.
Cboe is already spending to adapt, winning SEC approval in May 2026 to offer pre and post market sessions for select multi listed equity options starting July 13, 2026, per ir.cboe.com, May 2026. Longer hours widen the moat against Robinhood and Interactive Brokers fueled retail flow themes in recent commentary, but they also raise surveillance, staffing and clearing costs for flow that Nasdaq, NYSE American, MIAX and BOX will match within months. With capital expenditure of only $71.00M in 2025 against $4.71B of revenue, Cboe runs lean. A structural rule change would force that number up.
What would confirm this risk: The SEC advances a formal proposal on options order competition, best execution or access fees that targets internalization and auction mechanics Cboe relies on for price improvement.
4. Outside derivatives, Cboe is a price taker
In U.S. and Canadian equities, pan European trading and clearing, and institutional FX, Cboe competes as a fast follower, not a monopolist. Nasdaq and NYSE control listings gravity, dark pools and wholesalers internalize retail, and in FX, bank platforms and CME EBS dominate. That shows in the need to constantly defend share with pricing, rebates and acquisitions such as Cboe Canada, Cboe Australia and ErisX derived clearing experiments, while Data Vantage non transaction revenue, up 15% in the second quarter of 2026 per company materials summarized by investing.com, July 2026, still fights Bloomberg, Nasdaq and ICE data budgets.
The balance sheet gives room to compete, with $9.31B of assets, $4.17B of liabilities, $5.14B of stockholders equity, $2.22B of cash and cash equivalents and $1.59B of total debt including $1.44B of long term debt at year end 2025, plus return on equity of 26.3% and return on assets of 11.6%. But cash equities and FX are scale games where a 0.1 mil fee change moves share overnight. Persistent fee compression there would leave the 34.6% operating margin dependent on a single volatile derivatives spread.
What would confirm this risk: North American Equities, Europe and Asia Pacific and Global FX net revenue stagnates or declines for two consecutive quarters while Options and Futures grow, and management cites pricing, rebates or market share.
5. The stock prices perfection with no insider cushion
Cboe closed at $272.86 on September 18, 2026, with a 17.2% one year return and a 137.9% five year return, but also 26.5% below the $371.18 52 week high and above the $227.15 low. Valuation is full for an exchange: trailing price to earnings of 21.27, forward price to earnings of 17.92 and enterprise value to EBITDA of 14.36, against a $315.64 mean analyst target and a hold recommendation. Free cash flow on a trailing yfinance basis was $678.25M, dividends paid were $284.30M in 2025 and buybacks were only $66.70M in 2025 after $204.80M in 2024, so the shareholder return is increasingly the dividend, not aggressive shrinkage.
Positioning amplifies a miss. Institutions hold 91.3% of shares across 1,424 holders and insiders hold 0.25%, so there is no founder buffer if growth disappoints. Any guide down from that mid to high teens organic growth outlook, any S&P license headline, or any low volatility quarter that breaks the record revenue streak turns a quality compounder into a crowded de rating, as late summer commentary about a sharp pullback from May highs and concentration in proprietary products qualitatively flagged.
What would confirm this risk: The stock falls 10% or more on a quarter where net revenue of around $731.6M and adjusted diluted earnings of around $3.56 fail to grow sequentially, and forward estimates for $315.64 are cut while the multiple compresses below a 17.92 forward earnings multiple.
Lessons
Cboe Global Markets, founded in 1973 in Chicago and renamed from CBOE Holdings in October 2017, is a Pari Passu style compounder built on licensed monopoly volume, software margins, and conservative balance sheet management. Per yfinance and SEC EDGAR, it pairs $4.71B in 2025 revenue with $28.50B in market cap and $27.72B in enterprise value.
1. Own the proprietary tollbooth, not the commodity lane
Cboe reports five segments: Options, North American Equities, Europe and Asia Pacific, Futures and Global FX. The economics concentrate in exclusive options and volatility franchises supported by strategic relationships with S&P Dow Jones Indices, LLC, Frank Russell Company and FTSE International Limited. That is why $4.71B in revenue becomes $1.93B in gross profit, a 54.1% gross margin, a 34.6% operating margin and a 26.7% profit margin, with FY2025 operating income of $1.47B on SEC EDGAR and net income of $1.10B. Commodity cash equities is a scale and rebate game, proprietary index options are a tax on hedging that cannot be shopped elsewhere.
2. Demand operating leverage with almost no reinvestment
With 1661 employees, Cboe generated $1.74B in EBITDA and $1.75B in operating cash flow in 2025 while spending only $-71.00M on capital expenditure. Return on equity was 26.3% and return on assets was 11.6%, on $9.31B in assets, $5.14B in equity and $2.22B in cash against $1.59B in total debt including $1.44B long term. It still returned cash with $-284.30M in dividends paid and $-66.70M in repurchases. The lesson: prefer volume businesses where the next contract costs pennies to process and cash builds, the opposite of capital intensive brokers living on idle cash spreads.
3. Add distribution without diluting the moat
Cboe bolted BZX and Cboe Canada listings, pan European derivatives and ETP listings, plus institutional Global FX, around the core U.S. options franchise. Assets grew from $6.81B in FY2021 to $9.31B in FY2025, equity from $3.60B to $5.14B, and cash from $341.90M to $2.22B, while liabilities moved only from $3.21B to $4.17B on SEC EDGAR. Acquire pipes that feed the tollbooth, never businesses that commoditize it.
4. Even boring compounders require entry discipline
At $272.86, Cboe sits below its $371.18 52 week high and above its $227.15 52 week low, after a 17.2% one year return and a 137.9% five year return inside a five year range of $99.53 to $364.92. It trades at 21.27 times trailing earnings, 17.92 times forward earnings and 14.36 times EV to EBITDA, on 22.9% revenue growth and $10.42 in diluted EPS, with a mean target of $315.64 and a hold recommendation. Headline talk about an improved revenue outlook and another record year for options volume frames the bull case qualitatively, but the investing lesson is price discipline: pay a hold multiple for a tollbooth, not a growth multiple, and let $1.10B in earnings and net cash do the compounding.